Welcome to LookChem.com Sign In|Join Free

CAS

  • or

145654-01-9

Post Buying Request

145654-01-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

145654-01-9 Usage

General Description

4-METHOXY-3-(2-PROPYNYLOXY)BENZENECARBALDEHYDE is a chemical compound with the molecular formula C12H12O3. It is a white solid that is soluble in organic solvents, but insoluble in water. 4-METHOXY-3-(2-PROPYNYLOXY)BENZENECARBALDEHYDE is used as a flavoring agent and fragrance ingredient in the production of perfumes, soaps, and other personal care products. It has a sweet, aromatic odor and is commonly found in essential oils and natural extracts. Additionally, it has been used as a building block in the synthesis of various pharmaceuticals, particularly those with analgesic and anti-inflammatory properties. However, it is important to handle this compound with care, as it can be harmful if ingested, inhaled, or in contact with the skin.

Check Digit Verification of cas no

The CAS Registry Mumber 145654-01-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,5,6,5 and 4 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 145654-01:
(8*1)+(7*4)+(6*5)+(5*6)+(4*5)+(3*4)+(2*0)+(1*1)=129
129 % 10 = 9
So 145654-01-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H10O3/c1-3-6-14-11-7-9(8-12)4-5-10(11)13-2/h1,4-5,7-8H,6H2,2H3

145654-01-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-methoxy-3-prop-2-ynoxybenzaldehyde

1.2 Other means of identification

Product number -
Other names 4-methoxy-3-prop-2-ynyloxybenzaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:145654-01-9 SDS

145654-01-9Relevant articles and documents

Synthesis and neuroprotective effects of novel chalcone-triazole hybrids

Sooknual, Pichjira,Pingaew, Ratchanok,Phopin, Kamonrat,Ruankham, Waralee,Prachayasittikul, Supaluk,Ruchirawat, Somsak,Prachayasittikul, Virapong

, (2020)

The development of novel neuroprotective agents is urgently needed for the treatment of neurodegenerative diseases, affecting aging individuals worldwide. In this study, a new set of chalcone-triazole hybrids (6a-g) was synthesized and evaluated for their

Anti-leishmanial click modifiable thiosemicarbazones: Design, synthesis, biological evaluation and in silico studies

Temraz, Mohamed G.,Elzahhar, Perihan A.,El-Din A. Bekhit, Alaa,Bekhit, Adnan A.,Labib, Hala F.,Belal, Ahmed S.F.

, p. 585 - 600 (2018)

Leishmaniasis is a devastating tropical disease with limited therapeutic options. Depending on recently reported active anti-leishmanial compounds, we designed and synthesized a series of click modifiable 1,2,3-triazole and thiosemicarbazone hybrids. Most

A strategic approach to the synthesis of ferrocene appended chalcone linked triazole allied organosilatranes: Antibacterial, antifungal, antiparasitic and antioxidant studies

Singh, Gurjaspreet,Arora, Aanchal,Kalra, Pooja,Maurya, Indresh Kumar,Ruizc, Cristobal Espinosa,Estebanc, M. Angeles,Sinha, Shweta,Goyal, Kapil,Sehgal, Rakesh

, p. 188 - 195 (2019)

A series of ferrocene appended chalcone allied triazole coupled organosilatranes (FCTSa 7–FCTSa 12) were synthesised with the aim of amalgamating the pharmacological action of the constituting moieties into a single molecular scaffold. All the synthesised

APOPTOSIS INHIBITORS

-

Paragraph 0376, (2018/02/27)

The invention provides compounds that are inhibitors or covalent modifiers of succinate dehydrogenase subunit B (SDHB) and/or inhibitors of apoptosis, and pharmaceutically acceptable salts, hydrides and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 145654-01-9